We are live on ! Find out more
ARCK

Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock

Delisted

ARCK was delisted on the 12th of January, 2023.

62 hedge funds and large institutions have $152M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 8

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

10% more capital invested

Capital invested by funds: $139M → $152M (+$13.4M)

5% more funds holding

Funds holding: 5962 (+3)

Holders
62
Holders Change
+3
Holders Change %
+5.08%
% of All Funds
1.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
16
Reduced
8
Closed
7
Calls
$34K
Puts
Net Calls
+$34K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Saba Capital Management
New York
$16.5M +$2.52M +250,000 +18%
HCM
2
Highbridge Capital Management
New York
$8.91M +$2.13M +211,259 +32%
Marshall Wace
3
Marshall Wace
United Kingdom
$7.35M
CSS
4
Cubist Systematic Strategies
Connecticut
$6.77M +$1.44M +142,154 +27%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$6.1M
CF
6
Cantor Fitzgerald
New York
$5.6M -$9.09M -900,000 -62%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$5.06M +$5.05M +500,000 New
AC
8
Aristeia Capital
Connecticut
$4.55M
PC
9
Periscope Capital
Ontario, Canada
$4.48M
AA
10
AQR Arbitrage
Connecticut
$4.33M +$816K +80,800 +23%
CC
11
Centiva Capital
New York
$3.96M +$2.81M +278,700 +250%
CCM
12
Context Capital Management
California
$3.93M
UOC
13
UBS O'Connor
Illinois
$3.86M -$386K -38,221 -9%
SC
14
Sculptor Capital
New York
$3.76M +$9.1K +901 +0.2%
Calamos Advisors
15
Calamos Advisors
Illinois
$3.54M +$3.53M +350,000 New
DKCM
16
Davidson Kempner Capital Management
New York
$3.54M
RCM
17
Radcliffe Capital Management
Pennsylvania
$3.14M +$100K +9,900 +3%
SCM
18
Shaolin Capital Management
Florida
$3.1M +$1.32M +130,870 +75%
MI
19
MMCAP International
Cayman Islands
$3.04M
FTCM
20
Fir Tree Capital Management
New York
$2.98M -$1.57M -155,500 -35%
WAM
21
Wolverine Asset Management
Illinois
$2.86M +$920K +91,158 +48%
WRBC
22
W.R. Berkley Corp
Connecticut
$2.82M +$816K +80,800 +41%
BCM
23
Basso Capital Management
Connecticut
$2.78M -$311K -30,850 -10%
KIM
24
Karpus Investment Management
New York
$2.7M -$156K -15,475 -5%
ACM
25
Atalaya Capital Management
New York
$2.66M +$2.64M +261,895 New

ARCK Hedge Fund Activity: Q3 2022 in Review

62 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q3 2022, worth a combined $152M — up 9.6% from $139M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ARCK positions and 7 closed out — a net gain of 3 holders — while 16 added to existing stakes and 8 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $5.05M. The largest seller was Cantor Fitzgerald, cutting an estimated $9.09M.

  • 62 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q3 2022, up from 59 in Q2 2022.
  • Funds reported $152M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q3 2022, up 9.6% quarter-over-quarter.
  • 10 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q3 2022 and 7 closed out, a net change of +3 holders.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $5.05M added.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q3 2022 was Cantor Fitzgerald, an estimated $9.09M sold.

Based on aggregated 13F filings for Q3 2022.